Institute of Medical Sciences, Temerty Faculty of Medicine, University of Toronto, Canada; Department of Psychiatry, Vanderbilt University, Nashville, TN, USA; Hartford Hospital and Department of Psychiatry and Behavioural Sciences, Yale University, New Haven, CT, USA; Department of Psychiatry, University of Toronto, Canada; Addictions Division and Institute for Mental Health Policy and Research, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Institute of Medical Sciences, Temerty Faculty of Medicine, University of Toronto, Canada; Department of Psychiatry, Vanderbilt University, Nashville, TN, USA; Hartford Hospital and Department of Psychiatry and Behavioural Sciences, Yale University, New Haven, CT, USA; Department of Psychiatry, University of Toronto, Canada; Addictions Division and Institute for Mental Health Policy and Research, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Schizophr Res. 2024 May;267:86-98. doi: 10.1016/j.schres.2024.03.016. Epub 2024 Mar 25.
Auditory verbal hallucinations (AVH) are a disabling symptom for people with schizophrenia (SCZ), and do not always respond to antipsychotics. Repetitive transcranial magnetic stimulation (rTMS) has shown efficacy for medication-refractory AVH, though the underlying neural mechanisms by which rTMS produces these effects remain unclear. This systematic review evaluated the structural and functional impact of rTMS for AVH in SCZ, and its association with clinical outcomes.
A systematic search was conducted in Medline, PsychINFO, and PubMed using terms for four key concepts: AVH, SCZ, rTMS, neuroimaging. Using PRISMA guidelines, 18 studies were identified that collected neuroimaging data of an rTMS intervention for AVH in SCZ. Risk of bias assessments was conducted.
Low frequency (<5 Hz) rTMS targeting left hemispheric language processing regions may normalize brain abnormalities in AVH patients at structural, functional, electrophysiological, and topological levels, with concurrent symptom improvement. Amelioration of aberrant neural activity in frontotemporal networks associated with speech and auditory processing was commonly observed, as well as in cerebellar and emotion regulation regions. Neuroimaging analyses identified neural substrates with direct correlations to post-rTMS AVH severity, propounding their use as therapeutic targets.
Combined rTMS-neuroimaging highlights the multidimensional alterations of rTMS on brain activity and structure in treatment-resistant AVH, which may be used to develop more efficacious therapies. Larger randomized, sham-controlled studies are needed. Future studies should explore alternate stimulation targets, investigate the neural effects of high-frequency rTMS and evaluate long-term neuroimaging outcomes.
幻听是精神分裂症患者致残的症状,并不总是对抗精神病药物有反应。重复经颅磁刺激(rTMS)已显示出对药物难治性幻听的疗效,但 rTMS 产生这些效果的潜在神经机制仍不清楚。本系统评价评估了 rTMS 对精神分裂症幻听的结构和功能影响,及其与临床结果的关系。
使用 AVH、SCZ、rTMS 和神经影像学四个关键概念的术语,在 Medline、PsychINFO 和 PubMed 中进行了系统搜索。使用 PRISMA 指南,确定了 18 项研究,这些研究收集了 rTMS 干预精神分裂症幻听的神经影像学数据。对偏倚风险进行了评估。
针对左半球语言处理区域的低频(<5 Hz) rTMS 可能会使幻听患者的大脑异常在结构、功能、电生理和拓扑水平上正常化,同时症状也得到改善。通常观察到与言语和听觉处理相关的额颞网络以及小脑和情绪调节区域的异常神经活动得到改善。神经影像学分析确定了与 rTMS 后幻听严重程度直接相关的神经基质,提出了将其用作治疗靶点的可能性。
rTMS-神经影像学的结合强调了 rTMS 对治疗抵抗性幻听的大脑活动和结构的多维改变,这可能有助于开发更有效的治疗方法。需要更大的随机、假对照研究。未来的研究应探索替代刺激靶点,研究高频 rTMS 的神经效应,并评估长期神经影像学结果。